Prosecution Insights
Prosecution Insights
17 pending office actions • 13 art units • 17 examiners • 0 of 17 (0%) have an AI response strategy ready • 24 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (6%) |
| §101 + other | 3 (18%) |
| §103 only | 8 (47%) |
| §102 only | 1 (6%) |
| §112 only | 1 (6%) |
| Multi-statute (no §101) | 3 (18%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAMMOND, ELLEN CHRISTINA | 1 | 78.1% | +11.7% |
| REILLY, SOPHIA JANE | 1 | 60.6% | +49.1% |
| TATGE, LEXUS MARC | 1 | 50.0% | +100.0% |
| BOWERS, ERIN M | 1 | 55.1% | +10.5% |
| LEE, TSU-CHANG | 1 | 72.8% | +14.4% |
| CHEONG, CHEOM-GIL | 1 | 64.0% | +51.7% |
| CORDAS, EMILY ANN | 1 | 50.4% | +58.1% |
| DONOHUE, SEAN R | 1 | 41.4% | +21.1% |
| FABIAN JR, ROBERTO | 1 | 70.3% | +26.5% |
| COUGHLIN, DANIEL F | 1 | 39.0% | +18.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18297805 | SOLUBLE TREM2 PROTEIN AND USES THEREOF | BUNNER, BRIDGET E | 10d overdue |
| 19001104 | EYELID SPECULUM | HAMMOND, ELLEN CHRISTINA | — |
| 18778440 | DIAGNOSIS OF IMMUNITY REDUCTION THROUGH INTESTINAL MICROFLORA ANALYSIS OF STOMACH CANCER PATIENTS, AND THERAGNOSTIC COMPOSITION USING INTESTINAL MICROFLORA | REILLY, SOPHIA JANE | — |
| 18658276 | EXTRAMAMMARY PAGET DISEASE BIOMARKERS AND USES THEREOF | BOWERS, ERIN M | — |
| 18623731 | METHOD FOR GENERATING INFECTIOUS DISEASE PREDICTION KEYWORD THAT CHANGES OVER TIME BASED ON WORD EMBEDDING AND APPARATUS PERFORMING THE SAME | LEE, TSU-CHANG | — |
| 18535296 | SPECIMEN CYTOLOGY SUPPORTING DEVICE AND METHOD ACCORDING TO CELL STAINING METHOD | CORDAS, EMILY ANN | — |
| 18288667 | CANCER-SPECIFIC POLYPEPTIDE AND USE THEREOF | DONOHUE, SEAN R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18377504 | DEVICE MEASURING THE DEFOCUS CURVE OF A MULTIFOCAL INTRAOCULAR LENS | FABIAN JR, ROBERTO | 30d overdue |
| 19001104 | EYELID SPECULUM | HAMMOND, ELLEN CHRISTINA | — |
| 18778440 | DIAGNOSIS OF IMMUNITY REDUCTION THROUGH INTESTINAL MICROFLORA ANALYSIS OF STOMACH CANCER PATIENTS, AND THERAGNOSTIC COMPOSITION USING INTESTINAL MICROFLORA | REILLY, SOPHIA JANE | — |
| 18659711 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COLON CANCER INCLUDING EXTRACELLULAR VESICLES LOADED WITH MACC1 INHIBITOR AS ACTIVE INGREDIENT | TATGE, LEXUS MARC | — |
| 18658276 | EXTRAMAMMARY PAGET DISEASE BIOMARKERS AND USES THEREOF | BOWERS, ERIN M | — |
| 18623731 | METHOD FOR GENERATING INFECTIOUS DISEASE PREDICTION KEYWORD THAT CHANGES OVER TIME BASED ON WORD EMBEDDING AND APPARATUS PERFORMING THE SAME | LEE, TSU-CHANG | — |
| 18417720 | IMMUNOMODULATING COMPOSITION CONTAINING GASSERI | CHEONG, CHEOM-GIL | — |
| 18535296 | SPECIMEN CYTOLOGY SUPPORTING DEVICE AND METHOD ACCORDING TO CELL STAINING METHOD | CORDAS, EMILY ANN | — |
| Art Unit | Apps |
|---|---|
| 1634 | 2 |
| 3773 | 1 |
| 1653 | 1 |
| 1645 | 1 |
| 1632 | 1 |
| 1618 | 1 |
| 2877 | 1 |
| 1619 | 1 |
| 3682 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19001104 | EYELID SPECULUM | HAMMOND, ELLEN CHRISTINA | 3773 | §101§102 | Non-Final OA | — | Pending | Dec 24, 2024 |
| 18778440 | DIAGNOSIS OF IMMUNITY REDUCTION THROUGH INTESTINAL MICROFLORA ANALYSIS OF STOMACH CANCER PATIENTS, AND THERAGNOSTIC COMPOSITION USING INTESTINAL MICROFLORA | REILLY, SOPHIA JANE | — | §102§103§112 | Non-Final OA | — | Pending | Jul 19, 2024 |
| 18659711 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COLON CANCER INCLUDING EXTRACELLULAR VESICLES LOADED WITH MACC1 INHIBITOR AS ACTIVE INGREDIENT | TATGE, LEXUS MARC | — | §112 | Non-Final OA | — | Pending | May 09, 2024 |
| 18658276 | EXTRAMAMMARY PAGET DISEASE BIOMARKERS AND USES THEREOF | BOWERS, ERIN M | 1653 | §101§103§112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18623731 | METHOD FOR GENERATING INFECTIOUS DISEASE PREDICTION KEYWORD THAT CHANGES OVER TIME BASED ON WORD EMBEDDING AND APPARATUS PERFORMING THE SAME | LEE, TSU-CHANG | — | §101 | Non-Final OA | — | Pending | Apr 01, 2024 |
| 18417720 | IMMUNOMODULATING COMPOSITION CONTAINING GASSERI | CHEONG, CHEOM-GIL | 1645 | §102 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18535296 | SPECIMEN CYTOLOGY SUPPORTING DEVICE AND METHOD ACCORDING TO CELL STAINING METHOD | CORDAS, EMILY ANN | 1632 | §103§112 | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18288667 | CANCER-SPECIFIC POLYPEPTIDE AND USE THEREOF | DONOHUE, SEAN R | 1618 | §103§112 | Final Rejection | — | Pending | Oct 27, 2023 |
| 18377504 | DEVICE MEASURING THE DEFOCUS CURVE OF A MULTIFOCAL INTRAOCULAR LENS | FABIAN JR, ROBERTO | 2877 | §103 | Non-Final OA | 30d overdue | Pending | Oct 06, 2023 |
| 18370598 | COMPOSITION FOR IMMUNE TREATMENT OF ALLERGIC DISEASES COMPRISING HOUSE DUST MITE ANTIGENS AND HYALURONIC ACID HYDROGELS AS ACTIVE INGREDIENTS | COUGHLIN, DANIEL F | 1619 | §103 | Non-Final OA | — | Pending | Sep 20, 2023 |
| 18450703 | METHOD FOR PREDICTING THE OCCURRENCE OF POSTOPERATIVE ACUTE KIDNEY INJURY AND SYSTEM THEREOF | VAN DUZER, ALEXIS KIM | 3682 | §103 | Non-Final OA | 29d overdue | Pending | Aug 16, 2023 |
| 18342930 | LUNG CANCER MODELING USING NORMAL LUNG ORGANOID WITH LUNG CANCER CELLS | CANDELARIA, JULIANA IRENE | 1634 | §103 | Final Rejection | 14d | Pending | Jun 28, 2023 |
| 18254912 | METHOD FOR FABRICATING MICROROBOT FOR DELIVERY OF CELL THERAPY PRODUCT AND MICROROBOT ACCORDING THERETO | MACH, ANDRE | 1615 | §103 | Final Rejection | 26d | Pending | May 30, 2023 |
| 18297805 | SOLUBLE TREM2 PROTEIN AND USES THEREOF | BUNNER, BRIDGET E | 1647 | §101§102§112 | Final Rejection | 10d overdue | Pending | Apr 10, 2023 |
| 18191756 | EYEBALL AND EYELID PROTECTOR | SIRCAR, ALISHA JITENDRA | 3792 | §103 | Final Rejection | 8d | Pending | Mar 28, 2023 |
| 17794823 | NOVEL COMPOUND AND USE THEREOF | CORNET, JEAN P | 1628 | §103 | Final Rejection | 4d overdue | Pending | Jul 22, 2022 |
| 17268635 | PHARMACEUTICAL COMPOSITION FOR TREATING CARTILAGE DAMAGE, COMPRISING NASAL SEPTUM CHONDROCYTES | RIGA, MICHAEL ANGELO | 1634 | §103 | Final Rejection | — | Pending | Feb 16, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial